Evidence for CXCL16 as a Potent Angiogenic Mediator and Endothelial Progenitor Cell Chemotactic Factor Scientists examined the possibility that CXCL16 recruits endothelial cells to developing neovasculature in rheumatoid arthritis synovium. Human dermal microvascular endothelial cells and endothelial progenitor cells from human cord blood were also examined for CXCR6 expression by immunofluorescence and signaling activity for CXCL16. [Arthritis Rheum] Abstract
Methods of Freezing Cord Blood Hematopoietic Stem Cells The authors compared the effect of two-step cryopreservation and controlled-rate freezing method on the post-thaw quality of cord blood (CB) and evaluated the post-thaw quality of hematopoietic stem cell fractions isolated from CB with various methods and frozen with controlled-rate freezing method. [Transfusion] Abstract
The Characteristic Expression Pattern of BMI-1 and SALL4 Genes in Placenta Tissue and Cord Blood SALL4 and BMI-1 are important factors in hematopoiesis. Placental tissue (PT) and umbilical cord blood (CB) are rich in hematopoietic stem/progenitor cells, but their SALL4 and BMI-1 expression levels remain unknown. Real-time PCR was used to determine the expression level of these genes in PT and CB from ten cases, and ten healthy donors were used as control. [Stem Cell Res Ther] Abstract | Full Article
Role of CD271 Enrichment in the Isolation of Mesenchymal Stromal Cells from Umbilical Cord Blood Isolation of mesenchymal stromal cells (MSCs) from the umbilical cord blood (UCB) has a success rate of 25% and is frequently contaminated by osteoclast-like cells. CD271 is a well-known marker for the enrichment of bone marrow MSCs. Researchers assessed the effect of CD271 isolation on the isolation rate of MSCs from UCB. [Cell Biol Int] Abstract
REVIEWS
Pluripotent Possibilities: Human Umbilical Cord Blood Cell Treatment after Neonatal Brain Injury The pluripotent capacity of stem cells from the human umbilical cord blood provides simultaneous targeting of multiple neuropathologic events initiated by a hypoxic-ischemic insult. Their high regenerative potential and naïve immunologic phenotype makes them a preferable choice for transplantation. [Pediatr Neurol] Abstract
Visit our reviews page to see a complete list of reviews in the cord blood research field.
STEMCELL Technologies Inc. Obtains License from iPS Academia Japan for Induced Pluripotent Stem Cell Technologies STEMCELL Technologies Inc. has signed an agreement to license iPS Academia Japan’s induced pluripotent stem cell (iPS cell) technologies. This agreement will enable STEMCELL Technologies to develop media that are optimized for cellular reprogramming, further expanding its extensive portfolio of products designed to facilitate cutting-edge pluripotent stem cell research. [STEMCELL Technologies Inc.] Press Release
Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization's career opportunities on the Connexon Creative Job Board at no cost.
Have we missed an important article or publication in Cord Blood News? Click here to submit!